Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Debt / NOTE 3.000%10/1
-
Unit price / market price
-
$0.7526
-
Total 13F principal
-
$161,228,700
-
Principal change
-
+$105,700
-
Total reported value
-
$131,158,902
-
Number of holders
-
17
-
Value change
-
-$7,147,490
-
Number of buys
-
7
-
Number of sells
-
8
Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 as of Q3 2021
As of 30 Sep 2021 KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 had 17 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $161,228,700 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included CITADEL ADVISORS LLC, Davidson Kempner Capital Management LP, LAZARD ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, Opti Capital Management, LP, CNH PARTNERS LLC, STEELHEAD PARTNERS LLC, CAPSTONE INVESTMENT ADVISORS, LLC, Verition Fund Management LLC, and JPMORGAN CHASE & CO.
This table shows 17 bond principal holders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.